Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AlconCHIX:ALCZ -0.86%76 14-Day RSI is 56.32 as of Aug. 06, 2026. GuruFocus rates CHIX:ALCZ with a GF Score™ of 76/100 and a GF Value™ of CHF74.21 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Alcon ranks worse than 73.79% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-06), Alcon's 14-Day RSI is 56.32.
The industry rank for Alcon's 14-Day RSI or its related term are showing as below:
CHIX:ALCz's 14-Day RSI is ranked worse than 73.79% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 50.49
vs CHIX:ALCz: 56.32
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Alcon 14-Day RSI Related Terms
CHIX:ALCZ vs ISRG, BDX, MDLN: 14-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Alcon's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Alcon's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon (CHIX:ALCZ) has a 14-Day RSI of 56.32 as of Aug. 06, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Alcon and its competitors. According to the industry distribution chart, Alcon ranks #639 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 73.8%.
Is Alcon's 14-Day RSI too high?
Alcon's current 14-Day RSI is 56.32. The Medical Devices & Instruments industry median 14-Day RSI is 50.49. Alcon's value of 56.32 is 11.5% above this industry median. Based on the distribution chart, Alcon ranks #639 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Alcon has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's 14-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #639 out of 866 companies for 14-Day RSI. This places Alcon in the lower half of its industry. The industry median 14-Day RSI is 50.49. Alcon's value of 56.32 is 11.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 50.49, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current 14-Day RSI of 56.32 is 11.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Alcon and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 50.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current 14-Day RSI is 56.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (CHIX:ALCZ) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF74.21, compared to a current price of CHF56.74 — trading 23.5% below its estimated fair value. The current 14-Day RSI is 56.32 and 11.5% above the Medical Devices & Instruments industry median of 50.49. Alcon's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Alcon (CHIX:ALCZ), the current 14-Day RSI is 56.32 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (CHIX:ALCZ) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of CHF56.74 is trading 23.5% below its estimated GF Value™ of CHF74.21.
GuruFocus considers Alcon to be Modestly Undervalued.
Key valuation signals for CHIX:ALCZ:
14-Day RSI: 56.32
GF Value™: CHF74.21 vs. price of CHF56.74 (23.5% below fair value)
Industry Position: 11.5% above the Medical Devices & Instruments median (#639 of 866)
No single metric tells the full story. See the CHIX:ALCZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
76GF Score
Get the complete analysis for CHIX:ALCZ
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ALCZ has been successfully added to your 
